Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Medpace Holdings IncTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Medpace Holdings Inc trades at $607 (market cap $16.90B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.9× Medpace Holdings Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

MEDPREGN
Market Cap
$16.90B$82.06B
Sector
TechnologyHealth
52-Week High
$620.59$812.27
52-Week Low
$393.42$555.51
Enterprise Value
$16.52B$76.77B
Dividend Yield
0.47%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN